The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study

PURPOSE: To evaluate the ocular-surface safety of a 0.001% benzalkonium chloride-containing tafluprost/timolol fixed combination (TTFC) in patients with primary open-angle glaucoma (POAG) or ocular hypertension who have inadequate intraocular pressure (IOP) control with latanoprost monotherapy. METH...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Ophthalmol
Hlavní autoři: Okumichi, Hideaki, Kiuchi, Yoshiaki, Baba, Tetsuya, Kanamoto, Takashi, Naito, Tomoko, Nakakura, Shunsuke, Tabuchi, Hitoshi, Nii, Hiroki, Sueoka, Chie, Sugimoto, Yosuke
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Clinical Trial Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5488791/
https://ncbi.nlm.nih.gov/pubmed/28790802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S136418
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky